Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 11, No. 3, 2004   

Free Abstract     Article (PDF 76 KB)     

Original Article · Originalarbeit

Inhibition of (-)-trans-(1S,2S)-U50488 Hydrochloride by Its Enantiomer in White Mice - a Placebo-Controlled, Randomized Study
R.M. Kuzeffa, M.N. Topashka-Anchevab, R.P. Mechevab

aGraduate School of Integrative Medicine, Swinburne University of Technology, Melbourne, Australia;
bInstitute of Zoology, Bulgarian Academy of Sciences, Sofia, Bulgaria

Forschende Komplementärmedizin und Klassische Naturheilkunde / Research in Complementary and Classical Natural Medicine 2004;11:144-149 (DOI: 10.1159/000079443)



 goto top of page Summary

Background: Previous studies have been performed to see if toxicity of optically active compounds may be inhibited by potentized preparations of their enantiomers. The present study is based on the hypothesis that the toxic effects of an optical isomer may be counteracted or reversed by the administration of a potentized preparation of one of its stereoisomers and in particular the enantiomer (patent applied for). Methods: The design was prospective, blind, randomized, and placebo-controlled. 210 ICR conventional mice were used. 105 mice were administered a mixture of (+)-U50488 hydrochloride homeopathic potencies prior to and during the experiment, and the other 105 were administered indistinguishable placebo. The first 52 mice were used to establish an LD50 of intraperitoneally administered (-)-U50488 hydrochloride under the conditions of this experiment. The estimated LD50 was 25 mg/kg. The remaining 158 mice were then administered this LD50 of (-)-U50488 HCl intraperitoneally. One mouse from the placebo group was excluded from the analysis because it died immediately after the possibly intravenous injection of (-)-U50488 HCl. Results: 67% of homeopathy mice survived compared with 47% of placebo mice. The end point for statistical analysis was the difference in survival between the placebo and homeopathy mice. The analysis was adjusted for mouse weight using a logistic regression (LR) model. The LR treatment odds ratio for survival of treatment mice relative to placebo mice was 2.301 and the LR treatment chi-square was 6.2030 (1 degree of freedom), which has a p-value of 0.0128. Consequently, we reject the null hypothesis of no treatment effect on survival. Conclusion: We conclude that toxicity of intraperitoneal injection of (-)-U50488 hydrochloride may be inhibited by administration of a mixture of potencies of its enantiomer.

Copyright © 2004 S. Karger GmbH, Freiburg



 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 15249748)
Download Citation



This journal is part of the fourth subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues



For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.




copyright  © 2010 S. Karger AG, Basel